Panel Urges Further Research to Determine which DCIS Patients may be Candidates for Less-Invasive Therapy – 1
Narrator: This is NIH Health Matters. An independent panel says appropriate diagnostic factors need to be identified to better predict the risk of developing breast cancer in women with ductal carcinoma in situ, also called DCIS.
Dr. Allegra: DCIS represents a spectrum of abnormal cells that happen to be confined to the breast duct.
Narrator: Dr. Carmen Allegra, panel chair and Chief of Hematology and Oncology at the University of Florida, explains DCIS.
Dr. Allegra: The disease is a risk factor for invasive breast cancer but itís important to understand that it is not invasive breast cancer.
Narrator: The natural course of DCIS if left untreated is not well understood. For details on the panel's recommendations, visit the website consensus.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Audio
NIH Audio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Audio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Audio is a service of the Office of Communications & Public Liaison.